Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
Biotherapeutics, and antimicrobial proteins in particular, are of increasing interest for human medicine. An important challenge in the development of such therapeutics is their potential immunogenicity, which can induce production of anti-drug-antibodies, resulting in altered pharmacokinetics, redu...
Main Authors: | Léa V. Zinsli, Noël Stierlin, Martin J. Loessner, Mathias Schmelcher |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037020305493 |
Similar Items
-
T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
by: Ruoxuan Sun, et al.
Published: (2024-12-01) -
New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
by: Yana Khlusevich, et al.
Published: (2022-06-01) -
Functional Deimmunization of Interferon Beta-1b by Identifying and Silencing Human T Cells Epitopes
by: Amin Moradi Hasan-Abad, et al.
Published: (2019-08-01) -
Specificity of the T Cell Response to Protein Biopharmaceuticals
by: Sylvain Meunier, et al.
Published: (2020-07-01) -
Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
by: Moustafa Hamze, et al.
Published: (2017-05-01)